Global Weight Loss Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Weight Loss Therapeutics Market Overview

• 1.1 Product Overview and Scope of Weight Loss Therapeutics
• 1.2 Classification of Weight Loss Therapeutics by Types
  • 1.2.1 Global Weight Loss Therapeutics Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Weight Loss Therapeutics Revenue Market Share by Types in 2018
  • 1.2.3 Appetite Suppression
  • 1.2.4 Increasing Body Metabolism
  • 1.2.5 Interfering with the Digestion Absorption Patterns
• 1.3 Global Weight Loss Therapeutics Market by Application
  • 1.3.1 Global Weight Loss Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospitals
  • 1.3.3 Specialized Clinics
  • 1.3.4 Retail Pharmacies
  • 1.3.5 Mail Order Pharmacies
  • 1.3.6 Others
• 1.4 Global Weight Loss Therapeutics Market by Regions
  • 1.4.1 Global Weight Loss Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Weight Loss Therapeutics Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Weight Loss Therapeutics Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Weight Loss Therapeutics Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Weight Loss Therapeutics Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Weight Loss Therapeutics Status and Prospect (2014-2024)
• 1.5 Global Market Size of Weight Loss Therapeutics (2014-2024)

2 Company Profiles

• 2.1 Abbott
  • 2.1.1 Business Overview
  • 2.1.2 Weight Loss Therapeutics Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Abbott Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Novartis AG
  • 2.2.1 Business Overview
  • 2.2.2 Weight Loss Therapeutics Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Novartis AG Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Arena Pharmaceuticals
  • 2.3.1 Business Overview
  • 2.3.2 Weight Loss Therapeutics Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Arena Pharmaceuticals Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Sanofi
  • 2.4.1 Business Overview
  • 2.4.2 Weight Loss Therapeutics Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Sanofi Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Pfizer
  • 2.5.1 Business Overview
  • 2.5.2 Weight Loss Therapeutics Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Pfizer Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Novo Nordisk
  • 2.6.1 Business Overview
  • 2.6.2 Weight Loss Therapeutics Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Novo Nordisk Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 VIVUS
  • 2.7.1 Business Overview
  • 2.7.2 Weight Loss Therapeutics Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 VIVUS Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Johnson & Johnson
  • 2.8.1 Business Overview
  • 2.8.2 Weight Loss Therapeutics Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Johnson & Johnson Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Orexigen Therapeutics
  • 2.9.1 Business Overview
  • 2.9.2 Weight Loss Therapeutics Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Orexigen Therapeutics Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Biocon
  • 2.10.1 Business Overview
  • 2.10.2 Weight Loss Therapeutics Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Biocon Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Eisai
  • 2.11.1 Business Overview
  • 2.11.2 Weight Loss Therapeutics Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Eisai Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Eli Lilly
  • 2.12.1 Business Overview
  • 2.12.2 Weight Loss Therapeutics Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Eli Lilly Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Roche
  • 2.13.1 Business Overview
  • 2.13.2 Weight Loss Therapeutics Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Roche Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Amgen
  • 2.14.1 Business Overview
  • 2.14.2 Weight Loss Therapeutics Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Amgen Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Zafgen
  • 2.15.1 Business Overview
  • 2.15.2 Weight Loss Therapeutics Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Zafgen Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)

3 Global Weight Loss Therapeutics Market Competition, by Players

• 3.1 Global Weight Loss Therapeutics Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Weight Loss Therapeutics Players Market Share
  • 3.2.2 Top 10 Weight Loss Therapeutics Players Market Share
• 3.3 Market Competition Trend

4 Global Weight Loss Therapeutics Market Size by Regions

• 4.1 Global Weight Loss Therapeutics Revenue and Market Share by Regions
• 4.2 North America Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 4.3 Europe Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 4.5 South America Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)

5 North America Weight Loss Therapeutics Revenue by Countries

• 5.1 North America Weight Loss Therapeutics Revenue by Countries (2014-2019)
• 5.2 USA Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 5.3 Canada Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)

6 Europe Weight Loss Therapeutics Revenue by Countries

• 6.1 Europe Weight Loss Therapeutics Revenue by Countries (2014-2019)
• 6.2 Germany Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 6.3 UK Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 6.4 France Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 6.5 Russia Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 6.6 Italy Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Weight Loss Therapeutics Revenue by Countries

• 7.1 Asia-Pacific Weight Loss Therapeutics Revenue by Countries (2014-2019)
• 7.2 China Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 7.3 Japan Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 7.4 Korea Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 7.5 India Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)

8 South America Weight Loss Therapeutics Revenue by Countries

• 8.1 South America Weight Loss Therapeutics Revenue by Countries (2014-2019)
• 8.2 Brazil Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Weight Loss Therapeutics by Countries

• 9.1 Middle East and Africa Weight Loss Therapeutics Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 9.3 UAE Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)

10 Global Weight Loss Therapeutics Market Segment by Type

• 10.1 Global Weight Loss Therapeutics Revenue and Market Share by Type (2014-2019)
• 10.2 Global Weight Loss Therapeutics Market Forecast by Type (2019-2024)
• 10.3 Appetite Suppression Revenue Growth Rate (2014-2024)
• 10.4 Increasing Body Metabolism Revenue Growth Rate (2014-2024)
• 10.5 Interfering with the Digestion Absorption Patterns Revenue Growth Rate (2014-2024)

11 Global Weight Loss Therapeutics Market Segment by Application

• 11.1 Global Weight Loss Therapeutics Revenue Market Share by Application (2014-2019)
• 11.2 Weight Loss Therapeutics Market Forecast by Application (2019-2024)
• 11.3 Hospitals Revenue Growth (2014-2019)
• 11.4 Specialized Clinics Revenue Growth (2014-2019)
• 11.5 Retail Pharmacies Revenue Growth (2014-2019)
• 11.6 Mail Order Pharmacies Revenue Growth (2014-2019)
• 11.7 Others Revenue Growth (2014-2019)

12 Global Weight Loss Therapeutics Market Size Forecast (2019-2024)

• 12.1 Global Weight Loss Therapeutics Market Size Forecast (2019-2024)
• 12.2 Global Weight Loss Therapeutics Market Forecast by Regions (2019-2024)
• 12.3 North America Weight Loss Therapeutics Revenue Market Forecast (2019-2024)
• 12.4 Europe Weight Loss Therapeutics Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Weight Loss Therapeutics Revenue Market Forecast (2019-2024)
• 12.6 South America Weight Loss Therapeutics Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Weight Loss Therapeutics Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology